GlassScriptPhysician profile
Arjun Saxena
NPI 1003934530
$144,142.16
in general payments reported to CMS, 2019-2025
29 companies · $30K in 2025
The $30K reported for 2025 was more than what 93% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $10K · 2021: $15K · 2022: $15K · 2023: $33K · 2024: $25K · 2025: $30K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $68K · Travel and Lodging: $16K · Food and Beverage: $3,353.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $68,250.00 |
| Travel and Lodging | $16,202.12 |
| Food and Beverage | $3,353.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Omnilife Science, INC | $79,976.57 | 2019-2025 | Omnibotics 3.0, Corin Technology, Omnibotics V 2.7 |
| Uoc USA INC | $35,879.21 | 2019-2025 | U2, Conformity, U-Motion II and Ustar II, U2, Psi, Psi |
| Ecential Robotics | $19,761.61 | 2025 | |
| Pacira Therapeutics, INC. | $3,625.00 | 2021 | |
| Medical Device Business Services, INC. | $1,108.47 | 2019-2021 | |
| Smith+Nephew, INC. | $991.29 | 2022-2024 | Pico 14, Cadence |
| Kci USA, INC. | $800.00 | 2020 | |
| Depuy Synthes Sales INC. | $343.27 | 2019-2024 | Na, Orthovisc |
| Stryker Corporation | $319.38 | 2023-2024 | Gamma, Hoffmann |
| Corin USA | $178.34 | 2019 | |
| Orthalign INC | $147.70 | 2023 | Orthalign Plus |
| Ferring Pharmaceuticals INC. | $140.52 | 2022-2025 | Euflexxa |
| Davol INC. | $138.09 | 2021-2022 | |
| Becton, Dickinson and Company | $129.18 | 2022 | |
| Bioventus LLC | $123.28 | 2022-2025 | Durolane, Gelsyn-3 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Restor3d, INC. | $102.00 | 2023 | |
| Spinal Elements, INC. | $70.69 | 2023 | |
| Heraeus Medical, LLC. | $60.15 | 2024-2025 | |
| Ethicon US, LLC | $48.65 | 2025 | Echelon; Endopath, Dermabond |
| Kerecis Limited | $29.39 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Heron Therapeutics, INC. | $27.03 | 2019-2025 | Aponvie |
| Acera Surgical, INC. | $24.39 | 2025 | Restrata Wound Matrix |
| Fidia Pharma USA INC. | $23.68 | 2025 | Hymovis |
| Boston Scientific Corporation | $20.08 | 2022 | |
| Baxter Healthcare | $19.99 | 2019 | |
| Orthofix Medical, INC. | $16.30 | 2024 | Physio-Stim |
| Horizon Therapeutics Plc | $13.47 | 2019 | |
| Molnlycke Health Care US, LLC | $13.20 | 2024 | Avance |
| Zimmer Biomet Holdings, INC. | $11.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arjun Saxena listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.